Oncolytics Biotech (ONCY) Income from Discontinued Operations (2014 - 2016)
Oncolytics Biotech's (ONCY) quarterly Income from Discontinued Operations came in at 169.0 in Q2 2016, up 121.92% year-on-year from 76.15 in Q3 2015, and up 121.92% on a QoQ basis from 771.0 in Q2 2015.
Oncolytics Biotech (ONCY) Income from Discontinued Operations (2014 - 2016) Analysis & Trends
Oncolytics Biotech (ONCY) has 3 years of Income from Discontinued Operations data on file, last reported at 169.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Oncolytics Biotech | 76.93 Mn | 76.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 169.00 |
| Jun 30, 2015 | -771.00 |
| Jun 30, 2014 | -3,546.00 |